As of the latest updates, the avian influenza A(H5N1) virus, commonly known as H5N1 bird flu, continues to be a significant concern globally, particularly in the United States.
In the U.S., the outbreak of H5N1 bird flu has been ongoing since late March 2024, when the virus was first detected in dairy cows, followed by the first human infections in early April 2024. The Centers for Disease Control and Prevention (CDC) has been actively engaged in a coordinated response with federal, state, and local partners to monitor and mitigate the spread of the virus.
As of January 28, 2025, over 11,065 wild birds have been detected with the virus across 51 jurisdictions in the U.S., and more than 153 million poultry have been affected as of February 4, 2025[2].
The CDC has emphasized that while the current public health risk to the general public remains low, individuals with job- or recreation-related exposures to infected animals are at increased risk. These include farmers, workers in poultry and dairy farms, backyard bird flock owners, animal care workers, and those with recreational exposure to animals such as hunters and wild bird watchers. The CDC has provided guidance on prevention and mitigation strategies, including the use of personal protective equipment (PPE), clinical testing, and post-exposure prophylaxis (PEP) with antiviral medication like oseltamivir[1].
There have been no identified cases of human-to-human transmission of the H5N1 virus in the U.S., and globally, limited, non-sustained human-to-human transmission has not been reported since 2007. However, the virus's dynamic nature and potential for spillover and pandemic pose ongoing concerns for health officials[1][3].
The CDC and its partners have made significant strides in monitoring, testing, and characterizing the virus. They have monitored over 10,600 people following exposure to infected animals, tested more than 73,000 specimens for influenza A, and identified 63 reported cases of H5 bird flu as of December 31, 2024. The agency is also conducting special laboratory studies to better understand the virus characteristics and is laying the groundwork for a potential H5 vaccination program if needed[1].
Globally, H5N1 bird flu has been widespread in wild birds for decades, leading to periodic outbreaks in commercial poultry and backyard bird flocks, as well as infections in wild terrestrial and marine mammals and domesticated animals. Since 1997, more than 970 human infections with H5N1 bird flu have been reported from 24 countries, with a fatality rate of approximately 50%[1].
In summary, while the immediate public health risk from H5N1 bird flu is considered low, the ongoing surveillance, testing, and preparedness efforts by the CDC and global health authorities are crucial in managing the outbreak and preparing for any potential escalation.
This content was created in partnership and with the help of Artificial Intelligence AI